Beethoven-C-Diff Vaccine Trial

The purpose of the study is to learn about how effective, safe and tolerable the Clostridiodes difficile (C. diff) vaccine is in decreasing the number of C difficile infections (pCDI) in adults 65 years of age or older. The participants will receive either the C. difficile vaccine or placebo (saline). A placebo does not contain any active ingredients.